Levi Gray-Rupp

Title: The Innovations of Levi Gray-Rupp

Introduction

Levi Gray-Rupp is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of biotechnology, particularly in the development of systems targeting prostate-specific membrane antigen (PSMA) and carbonic anhydrase 9 (CA9). His work has the potential to impact cancer treatment and diagnostics.

Latest Patents

Levi Gray-Rupp holds 1 patent for his innovative work titled "Systems targeting PSMA and CA9." This patent includes antibodies and chimeric priming receptors that bind PSMA, as well as antibodies and chimeric antigen receptors that bind CA9. The patent also describes systems of chimeric priming receptors that bind PSMA and chimeric antigen receptors that bind CA9, along with cells expressing such systems and methods of use thereof.

Career Highlights

Levi is currently employed at Arsenal Biosciences, Inc., where he continues to advance his research and development efforts. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Levi collaborates with talented individuals such as Angela Boroughs and Samuel A. Williams. Their combined efforts contribute to the innovative projects at Arsenal Biosciences, Inc.

Conclusion

Levi Gray-Rupp's contributions to biotechnology through his patent on systems targeting PSMA and CA9 exemplify the impact of innovative thinking in the medical field. His work continues to pave the way for advancements in cancer treatment and diagnostics.